Synaptogenix Inc (SNPX)

[InTheTrenches]

"My biggest concern is nobody is looking at or touching this."

Biotwitter "thought leaders" (Adam F/Alfredo F, etc) are only giving it a cursory look or aren't even reviewing it, so most of their "sheep" aren't digging much deeper. And I don't know of anyone else with a following on twitter (other than @KSSMDPhd) who gives it >50% chance of succeeding.

Unfortunately, Bryostatin Phase 2a (single dose, safe, PK/PD positive) doesn't give much readthrough to Phase 2b (7 doses across 12-weeks, double-blind placebo controlled) SIB results.

So we have to rely on the extensive preclinical mouse/mammal models published by Dr. Alkon, upbeat scientific presentations at conferences by Wilke/Alkon, and 3 compassionate-use patients.

It's either the buy of the 21st century or just another startup biotech. I believe we'll see positive results, but there's a lot of extrapolation in my belief. There's no certainty to results being positive, but the deeper one digs, the more intriguing this binary event looks.